Skip to main content
Premium Trial:

Request an Annual Quote

NCI Signs Site License for BioDiscovery's Nexus Software

NEW YORK (GenomeWeb News) – BioDiscovery said last week that the National Cancer Institute has obtained a site license for its Nexus Copy Number software, which is used to analyze and visualize chromosomal aberrations from microarray data.
 
Nexus Copy Number can integrate data from thousands of arrays along with their clinical annotations in a single project, the company said.
 
Financial terms of the licensing agreement were not disclosed.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.